E. Boersma et al., Predictors of cardiac events after major vascular surgery - Role of clinical characteristics, dobutamine echocardiography, and beta-blocker therapy, J AM MED A, 285(14), 2001, pp. 1865-1873
Citations number
22
Categorie Soggetti
General & Internal Medicine","Medical Research General Topics
Context Patients who undergo major vascular surgery are at increased risk o
f perioperative cardiac complications. High-risk patients can be identified
by clinical factors and noninvasive cardiac testing, such as dobutamine st
ress echocardiography (DSE); however, such noninvasive imaging techniques c
arry significant disadvantages. A recent study found that perioperative bet
a -blocker therapy reduces complication rates in high-risk individuals.
Objective To examine the relationship of clinical characteristics, DSE resu
lts, beta -blocker therapy, and cardiac events in patients undergoing major
vascular surgery.
Design and Setting Cohort study conducted in 1996-1999 in the following 8 c
enters: Erasmus Medical Centre and Sint Clara Ziekenhuis, Rotterdam, Twee S
teden Ziekenhuis, Tilburg, Academisch Ziekenhuis Utrecht, Utrecht, and Medi
sch Centrum Alkmaar, Alkmaar, the Netherlands; Ziekenhuis Middelheim, Antwe
rp, Belgium; and San Gerardo Hospital, Monza, Istituto di Ricovero e Cura a
Carattere Scientifico, San Giovanni Rotondo, Italy.
Patients A total of 1351 consecutive patients scheduled for major vascular
surgery; DSE was performed in 1097 patients (81%), and 360 (27%) received b
eta -blocker therapy.
Main Outcome Measure Cardiac death or nonfatal myocardial infarction within
30 days after surgery, compared by clinical characteristics, DSE results,
and beta -blocker use.
Results Forty-five patients (3.3%) had perioperative cardiac death or nonfa
tal myocardial infarction, In multivariable analysis, important clinical de
terminants of adverse outcome were age 70 years or older; current or prior
angina pectoris; and prior myocardial infarction, heart failure, or cerebro
vascular accident. Eighty-three percent of patients had less than 3 clinica
l risk factors. Among this subgroup, patients receiving beta -blockers had
a lower risk of cardiac complications (0.8% [2/263]) than those not receivi
ng beta -blockers (2.3% [20/855]), and DSE had minimal additional prognosti
c value. In patients with 3 or more risk factors (17%), DSE provided additi
onal prognostic information, for patients without stress-induced ischemia h
ad much lower risk of events than those with stress-induced ischemia (among
those receiving beta -blockers, 2.0% [1/50] vs 10.6% [5/47]). Moreover, pa
tients with limited stress-induced ischemia (1-4 segments) experienced fewe
r cardiac events (2.8%[1/36]) than those with more extensive ischemia (grea
ter than or equal to5 segments, 36% [4/11]).
Conclusion The additional predictive value of DSE is limited in clinically
low-risk patients receiving beta -blockers. In clinical practice, DSE may b
e avoided in a large number of patients who can proceed safely for surgery
without delay. In clinically intermediate- and high-risk patients receiving
beta -blockers, DSE may help identify those in whom surgery can still be p
erformed and those in whom cardiac revascularization should be considered.